288 related articles for article (PubMed ID: 31132270)
1. Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy.
Chao Y; Chen G; Liang C; Xu J; Dong Z; Han X; Wang C; Liu Z
Nano Lett; 2019 Jul; 19(7):4287-4296. PubMed ID: 31132270
[TBL] [Abstract][Full Text] [Related]
2. Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments.
Pan J; Hu P; Guo Y; Hao J; Ni D; Xu Y; Bao Q; Yao H; Wei C; Wu Q; Shi J
ACS Nano; 2020 Jan; 14(1):1033-1044. PubMed ID: 31935064
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of CD8
Zhang Y; Gao X; Yan B; Wen N; Lee WSV; Liang XJ; Liu X
ChemMedChem; 2022 Jan; 17(2):e202100656. PubMed ID: 34806311
[TBL] [Abstract][Full Text] [Related]
4. Magnetic hyperthermia enhances cell toxicity with respect to exogenous heating.
Sanz B; Calatayud MP; Torres TE; Fanarraga ML; Ibarra MR; Goya GF
Biomaterials; 2017 Jan; 114():62-70. PubMed ID: 27846403
[TBL] [Abstract][Full Text] [Related]
5. Magnetism-mediated targeting hyperthermia-immunotherapy in "cold" tumor with CSF1R inhibitor.
Fang Y; He Y; Wu C; Zhang M; Gu Z; Zhang J; Liu E; Xu Q; Asrorov AM; Huang Y
Theranostics; 2021; 11(14):6860-6872. PubMed ID: 34093858
[No Abstract] [Full Text] [Related]
6. Tumor microenvironment responsive FePt/MoS
Zhang D; Cui P; Dai Z; Yang B; Yao X; Liu Q; Hu Z; Zheng X
Nanoscale; 2019 Nov; 11(42):19912-19922. PubMed ID: 31599915
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer.
Gavilán H; Avugadda SK; Fernández-Cabada T; Soni N; Cassani M; Mai BT; Chantrell R; Pellegrino T
Chem Soc Rev; 2021 Oct; 50(20):11614-11667. PubMed ID: 34661212
[TBL] [Abstract][Full Text] [Related]
8. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
9. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.
Chen Q; Xu L; Liang C; Wang C; Peng R; Liu Z
Nat Commun; 2016 Oct; 7():13193. PubMed ID: 27767031
[TBL] [Abstract][Full Text] [Related]
10. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles.
Chauhan A; Midha S; Kumar R; Meena R; Singh P; Jha SK; Kuanr BK
Biomater Sci; 2021 Apr; 9(8):2972-2990. PubMed ID: 33635305
[TBL] [Abstract][Full Text] [Related]
11. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
12. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
[TBL] [Abstract][Full Text] [Related]
14. Liquid metal microspheres with an eddy-thermal effect for magnetic hyperthermia-enhanced cancer embolization-immunotherapy.
Yang N; Sun X; Zhou Y; Yang X; You J; Yu Z; Ge J; Gong F; Xiao Z; Jin Y; Liu Z; Cheng L
Sci Bull (Beijing); 2023 Aug; 68(16):1772-1783. PubMed ID: 37516662
[TBL] [Abstract][Full Text] [Related]
15. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
16. An injectable and active hydrogel induces mutually enhanced mild magnetic hyperthermia and ferroptosis.
Chen X; Wang H; Shi J; Chen Z; Wang Y; Gu S; Fu Y; Huang J; Ding J; Yu L
Biomaterials; 2023 Jul; 298():122139. PubMed ID: 37148756
[TBL] [Abstract][Full Text] [Related]
17. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
18. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
19. Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination.
Garanina AS; Naumenko VA; Nikitin AA; Myrovali E; Petukhova AY; Klimyuk SV; Nalench YA; Ilyasov AR; Vodopyanov SS; Erofeev AS; Gorelkin PV; Angelakeris M; Savchenko AG; Wiedwald U; Majouga Dr AG; Abakumov MA
Nanomedicine; 2020 Apr; 25():102171. PubMed ID: 32084594
[TBL] [Abstract][Full Text] [Related]
20. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
